Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Patients with Hematologic Malignancies Who Relapse following Autologous Transplantation: A Multi-Institutional Prospective Study from the Cancer and Leukemia Group B (CALGB trial 100002)
- Citation:
- Biol Blood Marrow Transplant vol 17 (4)
- Year:
- 2011
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Received
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Transplant
- Sec. Committees:
- Pharmas:
- Grants:
- CA33601, CA77597, CA11789, U10 CA077658, CA03927, U10 CA031946, U10 CA033601, CA59518, CA60138, U10 CA077597, U10 CA059518, U10 CA045418, U10 CA077440, CA77440, U10 CA047559, CA47559, CA45418, CA77658, CA31946, U10 CA003927
- Corr. Author:
- Authors:
- Asad Bashey Kouros Owzar Jeffrey L. Johnson Peggy S. Edwards Michael Kelly Lee-Ann Baxter-Lowe Steven Devine Sherif Farag David Hurd Edward Ball Philip McCarthy John Lister Thomas C. Shea Charles Linker
- Networks:
- Study
- CALGB-100002
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Article